Australian software developer Maxamine is making a killing in the US, recording an increase in revenues of 383 per cent over the past year.
Maxamine's software measures the effectiveness of Web sites by creating a visual report of how visitors move through a site and where barriers or bottlenecks occur. The software also provides reports that identify inappropriate content or links and other comprehensive details about the Web site structure.
The software has proved popular with corporates who must show an ROI on their Web site investments. The developer also claims the software allows corporates to exercise greater governance over the site, thereby minimising the potential for litigious actions against the company.
Founded in 1997, Maxamine has grown from its startup origins in Adelaide to become a global company with headquarters in San Ramon, California. It employs staff at three locations in the US - California, Dallas and Houston - and also employs an R&D engineering team in South Australia.
Steve Kirkby, Maxamine's CEO, said the success of the past year was due to the company's new business model. "We are now selling our software through major distributors who are trusted by their clients," he said.
Kirkby said that one of its most important partnerships in terms of strengthening Maxamine's global presence is its reseller agreement with services giant EDS, which opened up a significant customer base for the developer.
"EDS is playing an important role in establishing the credibility of our software with blue chip US corporates. Multinational corporates are coming to grips with site management challenges, and welcome the control and peace of mind that Maxamine brings. This year is just the beginning."
Its customer base includes such US-based companies as Silicon Graphics, Intel, Sun Microsystems, EDS, Netscape, Consolidated Edison, Wells Fargo, Cinergy and TXU. In Australia, Telstra, the Commonwealth Bank, ANZ, Macquarie Bank, Optus and NRMA are notable clients.
Kirkby said that the company will be expanding its operations in Europe and the US, and increasing the headcount at its South Australian office. He also revealed that Maxamine has recently made a full enterprise-wide licence sale in the US with an estimated worth of seven figures, but would not provide any further information.